Cancer Research UK scheme secures £280m buy-in with Standard Life

BPA deal secures the benefits of 2,800 scheme members

Holly Roach
clock • 2 min read
Cancer Research UK scheme secures £280m buy-in with Standard Life

The Cancer Research UK Pension Scheme has completed a £280m buy-in deal with Standard Life.

The bulk purchase annuity (BPA) transaction – completed in March using a "bespoke offering" – secures the benefits of 2,800 scheme members. Mercer was lead transaction adviser to the trustee, wh...

To continue reading this article...

Join Professional Pensions

Become a Professional Pensions Lite Member today

  • Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
  • Receive important and breaking news stories via our two daily news alerts
  • Hear from industry experts and other forward-thinking leaders

Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here

Join now

 

Already a Professional Pensions
member?

Login

Holly Roach
Author spotlight

Holly Roach

Deputy Editor at Professional Pensions

More on Risk Reduction

Avon Cosmetics secures £235m buy-in with M&G

Avon Cosmetics secures £235m buy-in with M&G

Transaction secures the benefits of over 3,000 scheme members

Holly Roach
clock 11 February 2026 • 1 min read
Vistry secures £155m multi-scheme buy-in deal with PIC

Vistry secures £155m multi-scheme buy-in deal with PIC

Transaction covers three final salary schemes, securing the benefits of 1,671 members

Holly Roach
clock 10 February 2026 • 1 min read
KLM UK Pension Scheme completes £240m buy-in with Rothesay

KLM UK Pension Scheme completes £240m buy-in with Rothesay

Transaction secures the benefits of the remaining 1,852 scheme members

Holly Roach
clock 10 February 2026 • 3 min read
Trustpilot